Meet Sentante’s CEO Edvardas Satkauskas | Interview by Joe Mullings
Joe Mullings sits down with Edvardas Satkauskas, CEO of Sentante, to discuss the company’s groundbreaking work in robotic surgery and the future of MedTech.
View Video
3:00
Sentante enables the remote manipulation of catheters and guidewires
for safe and rapid endovascular disease management
The manipulation of three endovascular instruments simultaneously allows the entire procedure to be performed robotically.
Physicians interface with the robot is via the same endovascular instruments as in a manual procedure
EPO
First patent application
Work in progress
Pre-clinical animal testing
Continuing patent applications
01
First use of the Sentante robotic system in human patients
Joe Mullings sits down with Edvardas Satkauskas, CEO of Sentante, to discuss the company’s groundbreaking work in robotic surgery and the future of MedTech.
🚀 A historic milestone in neurointervention! We’ve just performed the first fully robotic remote endovascular stroke thrombectomy in an animal model using the Sentante robot
Sentante is more than a robotic solution – it’s the key to unlocking the fully digitalized cath lab of the future. By collecting real-time data
🏆 𝐁𝐈𝐆 𝐖𝐈𝐍! 𝐒𝐞𝐧𝐭𝐚𝐧𝐭𝐞 has been recognized with an 𝐢𝐅 𝐃𝐞𝐬𝐢𝐠𝐧 𝐀𝐰𝐚𝐫𝐝 𝟐𝟎𝟐𝟓! ✨Out of 10,651 submissions across 82 categories, our work on Sentante stood out,
We are thrilled to welcome Marvin Slosman to our Business Advisory Board!With his expertise in commercialization and financial strategy, he will be instrumental in driving
Thousands of interventional specialists, vascular experts, and healthcare professionals from around the world gathered in Leipzig to engage in cutting-edge discussions, groundbreaking presentations, and hands-on learning experiences. 🔥 Sentante’s
With Sentante, we’ve created an interface where haptics finally make sense -bringing the feel of manual control into minimally invasive procedures. Sentante isn’t just about
We were proud to showcase Sentante at this year’s VEITHsymposium, giving attendees a hands-on opportunity to experience our 1:1 haptic feedback – a game-changer in
Sentante‘s debut at Houston Methodist’s advanced technology facility was an exciting moment! The inspiring feedback we’ve received about our system’s capabilities and ease of adoption highlights
The Sentante Endovascular Robotic System has hit a major milestone, completing its first in human clinical study led by Dainis Krievins, MD, PhD in Riga,
Sentante © Copyright 2023
UAB Inovatyvi Medicina
VAT LT100011754612
Vytauto pr. 23, Kaunas
44352, Lithuania
UAB Inovatyvi medicina
VAT LT100011754612
Vytauto pr. 23, Kaunas
44352, Lithuania